Equity Research Terminal

Fiscalypse

← All tickers

JNJ

Valuation analysis — P/E and P/S percentile bands, 35+ metrics

Health CareSEC EDGAR35+ METRICSFREEData thru 2026-09

P/E (TTM)

40.5×

P/S (TTM)

6.6×

EPS Growth

-35.9%

Rev Growth

+7.8%

10y Med P/E

22.9×

10y Med P/S

4.8×

P/E vs Hist

Above median

Enter a stock ticker to load the chart

AI readJNJ
SEC-grounded

Where JNJ's valuation sits in its own 10-year range, the biggest balance-sheet risk, and the price trend — written from its SEC filings, with follow-up chat.